Delivery Order SPE2DB20D3101-SPE2DB25FRSK6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $6,795.56 to AmerisourceBergen Drug Corp for 30-unit supplies of DESCOVY 200-25 mg tablets, an antiretroviral medication used in HIV treatment and prevention. The contract was competitively awarded without set-aside provisions and is classified as firm fixed price, with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $33,029.83 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $2,842.20 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, representing a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,954.30 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.61 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.52 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a $12,245.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a non-set-aside competitively awarded contract with an ultimate completion date of September 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSK6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,775.57 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is a prescription antiretroviral medication used in HIV treatment and prevention, and this delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. This delivery order is issued under AmerisourceBergen's substantial $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which serves as a comprehensive global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a wide range of medications, vaccines, and medical supplies to support military healthcare programs, the Defense Health Agency, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its capability to meet the Department of Defense's stringent pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/12/25 |